MVs derived from the platelet-poor plasma of patients with RA promoted the production of IL-6 and IL-8 and the expression of CD54+ in endothelial cells, as well as the adhesion of monocytes to the endothelium [231]. Here, IL6 is linked to rheumatoid arthritis.